OncoHost Raises $35 Million Series C Funding Round to Launch Blood Test That May Rewrite the Standard of Care for Precision Oncology
AI-Powered Precision Oncology Platform Enables Clinicians to Personalize Cancer Treatment Plans and Overcome Resistance OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced the completion of a $35 million…